The general objective of the iPAAC Joint Action (JA) is to develop innovative approaches to advances in cancer control. The innovation that will be covered within the JA consists of further development of cancer prevention, comprehensive approaches to the use of genomics in cancer control, cancer information and registries, improvements and challenges in cancer care, mapping of innovative cancer treatments and governance of integrated cancer control, including a new analysis of National Cancer Control Plans. The key focus of the Joint Action will be on implementation, as reflected in the key deliverable, i.e. the Roadmap on Implementation and Sustainability of Cancer Control Actions, which will support member states in the implementation of iPAAC and CANCON recommendations.
million EUR co-funding by EC
44 partners (Competent Authorities and Affiliated Entities)
21 Jan 2019
WP5 Conference on Early Detection
The WP5 Conference on Early Detection will take place on 20 May 2019 and will be hosted by the Hungarian National Institute of Oncology in Budapest.
18 Dec 2018
3rd Steering Committee meeting and 2nd Roadmap Coordination Committee meeting
The iPAAC SC meeting and RCC meeting will be held on 25 January 2019 in Brussels.
13 Dec 2018
2nd Governmental Board meeting
The iPAAC Governmental Board meeting, which will be held on Thursday 24 January 2019 in Brussels (Eurostation II Victor Hortaplein, 40 1060 Brussels).
30 Nov 2018
iPAAC Local Stakeholder Forum in Greece
The 7th Health Region of Crete, Greece (JA associated partner) organised its first iPAAC Local Stakeholder Forum on 18 November 2018 in Heraklion, Crete.